CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 21
- +1 vs. Q4 2021
- Portfolio value
- $235.0M
- −$66.3M (−22.0%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DTILPrecision Biosciences Inc | COM | 606,629 | $1.87M | 0.8% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 852,888 | $2.68M | 1.1% | +452,888+113.2% | Added | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,703,137 | $2.79M | 1.2% | +1,303,137+325.8% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 62,229 | $3.38M | 1.4% | +44,711+255.2% | Added | History |
| INZYInozyme Pharma, Inc. | COM | 892,057 | $3.65M | 1.6% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 488,635 | $3.71M | 1.6% | +258,635+112.5% | Added | History |
| ORTXOrchard Therapeutics plc | ADS | 5,307,751 | $3.78M | 1.6% | −1,142,105−17.7% | Reduced | History |
| CMPXCompass Therapeutics, Inc. | COM | 2,829,712 | $3.88M | 1.7% | −193,980−6.4% | Reduced | History |
| AKUSAkouos, Inc. | COM | 836,120 | $3.97M | 1.7% | 00.0% | Unchanged | History |
| ONCROncorus, Inc. | COM | 2,417,436 | $4.30M | 1.8% | +310,533+14.7% | Added | History |
| IMAImageneBio, Inc. | COM | 814,755 | $4.97M | 2.1% | −10.0% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 314,612 | $5.23M | 2.2% | +42,362+15.6% | Added | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 4,862,319 | $5.45M | 2.3% | +2,985,930+159.1% | Added | – |
| LRMRLarimar Therapeutics, Inc. | COM | 1,515,148 | $6.14M | 2.6% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 1,055,882 | $6.59M | 2.8% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 819,672 | $14.0M | 6.0% | +819,672 | New | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 3,084,310 | $14.5M | 6.2% | +408,902+15.3% | Added | – |
| PLRXPliant Therapeutics, Inc. | COM | 2,657,457 | $18.6M | 7.9% | +87,978+3.4% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 2,753,047 | $28.8M | 12.3% | +276,327+11.2% | Added | History |
| RPTXRepare Therapeutics Inc. | COM | 2,581,097 | $36.8M | 15.6% | +368,841+16.7% | Added | History |
| RXDXPrometheus Biosciences, Inc. | COM | 1,585,096 | $59.9M | 25.5% | −167,147−9.5% | Reduced | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $206.0K | – |